Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - HUMANIGEN, INC | ex32_2.htm |
| EX-32.1 - EXHIBIT 32.1 - HUMANIGEN, INC | ex32_1.htm |
| EX-31.2 - EXHIBIT 31.2 - HUMANIGEN, INC | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - HUMANIGEN, INC | ex31_1.htm |
| EX-21.1 - EXHIBIT 21.1 - HUMANIGEN, INC | ex21_1.htm |
| EX-10.40 - EXHIBIT 10.40 - HUMANIGEN, INC | ex10_40.htm |
| 10-K - HUMANIGEN, INC | p3217010k.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Forms S-8 (File Nos. 333-183725, 333-194597, 333-202934, 333-206321 and 333-214110) of KaloBios Pharmaceuticals, Inc. of our report dated March 9, 2017, relating to the consolidated financial statements of KaloBios Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K of KaloBios Pharmaceuticals, Inc. for the years ended December 31, 2016 and 2015.
/s/ HORNE LLP
Ridgeland, Mississippi
March 9, 2017